Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
James M. Frincke0
Date of Patent
May 24, 2011
Patent Application Number
12633721
Date Filed
December 8, 2009
Patent Primary Examiner
Patent abstract
The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the invention include methyl-2,3,4-trihydroxy-1-O-(7,17-dioxoandrost-5 -ene-3β-yl)-β-D-glucopyranosiduronate, 16α,3α-dihydroxy-5α-androstan-17-one or 3,7,16,17 -tetrahydroxyandrost-5-ene, 3,7,16,17-tetrahydroxyandrost-4-ene, 3,7,16,17 -tetrahydroxyandrost-1-ene or 3,7,16,17-tetrahydroxyandrostane that can be used in the treatment method.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
